AbstractObjective To investigate the role of miR-193a-3p in the radioresistance of esophageal squamous cell carcinoma (ESCC). Methods MTT assay was used to identify the cell lines with the highest radiosensitivity and radioresistance in four esophageal cancer cell lines exposed to irradiation of 6 MV X-ray. Stem-loop quantitative real-time PCR was used to measure the expression levels of miR-193a-3p, miR-155, and miR-22-3P in the two cell lines. Further studies were performed on miR-193a-3p because of the substantial difference in its expression between the two cell lines. The mimic (3PM) and antagomiR (3PA) of miR-193a-3p as well as siRNA (si-LOXL4) were synthesized and transfected into cells to elevate and inhibit miR-193a-3p expression. MTT assay and flow cytometry were used to evaluate the effects of miR-193a-3p and its downstream gene LOXL4 on radiosensitivity. Results KYSE510 and KYSE410 were characterized as cell lines with the highest radiosensitivity and radioresistance, respectively. miR-193a-3p had a substantially larger difference in expression between the two cell lines than miR-155 or miR-22-3P (1.00∶21.00). Transfection of 3PM resulted in elevated expression of miR-193a-3p in KYSE510, which had a significantly lower radiosensitivity and a significantly reduced apoptosis ratio by 11.01% compared with the control group (P<0.05). KYSE410 transfected with 3PA had a significantly higher radiosensitivity (P<0.05). The expression of LOXL4, a downstream gene of miR-193a-3p, was negatively correlated with miR-193a-3p expression. Transfection with si-LOXL4 inhibited the expression of LOXL4, which resulted in a significantly lower radiosensitivity and a significantly reduced apoptosis ratio by 7.07% compared with the control group (P<0.05). Conclusions miR-193a-3p promotes the radioresistance of esophageal cancer cells probably by regulation of LOXL4.
Meng Fang,Qian Liting,Ding Bojin et al. A preliminary study of the role of miR-193a-3p in radioresistance of esophageal cancer cells[J]. Chinese Journal of Radiation Oncology, 2016, 25(8): 872-878.
Meng Fang,Qian Liting,Ding Bojin et al. A preliminary study of the role of miR-193a-3p in radioresistance of esophageal cancer cells[J]. Chinese Journal of Radiation Oncology, 2016, 25(8): 872-878.
[1] Jemal A,Siegel R,Ward E,et al. Cancer statistics,2008[J].CA:Cancer J Clin,2008,58(2):71-96.DOI:10.3322/CA.2007.0010 [2] Jemal A,Bray F,Center MM,et al. Global cancer statistics[J].CA:Cancer J Clin,2011,61(2):69-90.DOI:10.3322/caac.20107 [3] Chen WQ,He YT,Zheng RS,et al. Esophageal cancer incidence and mortality in China,2009[J].J Thorac Dis,2013,5(1):19-26.DOI:10.3978/j.issn.2072-1439.2013.01.04 [4] Herskovic A,Martz K,Al-Sarraf M,et al. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus[J].New Engl J Med,1992,326(24):1593-1598.DOI:10.1056/NEJM199206113262403 [5] Bonner JA,Harari PM,Giralt J,et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck[J].New Engl J Med,2006,354(6):567-578.DOI:10.1056/NEJMoa053422 [6] Kim JJ,Tannock IF.Repopulation of cancer cells during therapy:an important cause of treatment failure[J].Nat Rev Cancer,2005,5(7):516-525.DOI:10.1038/nrc1650 [7] Metheetrairut C,Slack FJ.MicroRNAs in the ionizing radiation response and in radiotherapy[J].Curr Opin Genet Dev,2013,23(1):12-19.DOI:10.1016/j.gde.2013.01.002 [8] Lin RJ,Xiao DW,Liao LD,et al. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma[J].J Surg Oncol,2012,105(2):175-182.DOI:10.1002/jso.22066 [9] Liu C,Gao F,Li B,et al. TLR4 knockout protects mice from radiation-induced thymic lymphoma by downregulation of IL6 and miR-21[J].Leukemia,2011,25(9):1516-1519.DOI:10.1038/leu.2011.113 [10] Yong FL,Law CW,Wang CW.Potentiality of a triple microRNA classifier:miR-193a-3p,miR-23a and miR-338-5p for early detection of colorectal cancer[J].BMC Cancer,2013,13:280.DOI:10.1186/1471-2407-13-280 [11] Huang S,Li XQ,Chen X,et al. Inhibition of microRNA-21 increases radiosensitivity of esophageal cancer cells through phosphatase and tensin homolog deleted on chromosome 10 activation[J].Dis Esophagus,2013,26(8):823-831.DOI:10.1111/j.1442-2050.2012.01389.x [12] Lynam-Lennon L,Reynolds JV,Marignol L,et al. MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma[J].J Mol Med,2012,90(12):1449-1458.DOI:10.1007/s00109-012-0924-x [13] Zhou SN,Ye WG,Ren J,et al. MicroRNA-381 increases radiosensitivity in esophageal squamous cell carcinoma[J].Am J Cancer Res,2015,5(1):267-277 [14] Yu T,Li J,Yan M,et al. MicroRNA-193a-3p and-5p suppress the metastasis of human non-small-cell lung cancer by downregulating the ERBB4/PIK3R3/mTOR/S6K2 signaling pathway[J].Oncogene,2015,34(4):413-423.DOI:10.1038/onc.2013.574 [15] Deng H,Lv L,Li Y,et al. The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer[J].Biochim Biophys Acta,2015,1852(3):520-528.DOI:10.1016/j.bbadis.2014.12.014 [16] Lv L,Li Y,Deng H,et al. MiR-193a-3p promotes the multi-chemoresistance of bladder cancer by targeting the HOXC9 gene[J].Cancer Lett,2015,357(1):105-113.DOI:10.1016/j.canlet.2014.11.002 [17] Li Y,Deng H,Lv L,et al. The miR-193a-3p-regulated ING5 gene activates the DNA damage response pathway and inhibits multi-chemoresistance in bladder cancer[J].Oncotarget,2015,6(12):10195-10206.DOI:10.18632/oncotarget.3555 [18] Liang HW,Liu MH,Yan X,et al.miR-193a-3p functions as a tumor suppressor in lung cancer by down-regulating ERBB4[J].J Biol Chem,2015,290(2):926-940.DOI:10.1074/jbc. M114.621409 [19] Kwon JE,Kim BY,Kwak SY,et al. Ionizing radiation-inducible microRNA miR-193a-3p induces apoptosis by directly targeting Mcl-1[J].Apoptosis,2013,18(7):896-909.DOI:10.1007/s10495-013-0841-7 [20] Jiang WP,Sima ZH,Wang HC,et al. Identification of the involvement of LOXL4 in generation of keratocystic odontogenic tumors by RNA-Seq analysis[J].Int J Oral Sci,2014,6(1):31-38.DOI:10.1038/ijos.2013.96 [21] Tian MX,Liu WR,Jin L,et al. LOXL4 is downregulated in hepatocellular carcinoma with a favorable prognosis[J].Int J Clin Exp Pathol,2015,8(4):3892-3900
2016, Vol. 25 
